Physician profile
John E Cantrell
NPI 1588699839
$2,636.36
in general payments reported to CMS, 2019-2025
43 companies · $227 in 2025
The $227 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $706 · 2020: $466 · 2021: $490 · 2022: $384 · 2023: $199 · 2024: $164 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $590.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $590.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Brainlab, INC. | $490.37 | 2019 | |
| Amgen INC. | $259.48 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $140.48 | 2020-2023 | Lynparza, Keytruda |
| Astrazeneca Pharmaceuticals Lp | $131.31 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $126.30 | 2022-2023 | |
| Seagen INC. | $115.42 | 2020-2023 | Padcev |
| Daiichi Sankyo INC. | $103.87 | 2020-2025 | Enhertu |
| Lilly USA, LLC | $103.12 | 2021-2025 | Jaypirca, Verzenio |
| Intuitive Surgical, INC. | $103.09 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $97.38 | 2019-2025 | |
| Eisai INC. | $84.76 | 2019-2024 | |
| Exelixis INC. | $83.20 | 2020-2021 | |
| Incyte Corporation | $70.10 | 2020-2024 | Monjuvi |
| Janssen Biotech, INC. | $64.43 | 2021-2023 | Darzalex |
| Takeda Pharmaceuticals U.S.A., INC. | $48.56 | 2019-2020 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Cantrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.